Echo IQ Concludes Presentation Regarding Application for Category III CPT Code for EchoSolv AS in the US, Shares Fall 18%

MT Newswires Live
2025/09/19

Echo IQ (ASX:EIQ) said it concluded its presentation to the American Medical Association's CPT editorial panel meeting regarding its application for a category III current procedural technology (CPT) code for its EchoSolv aortic stenosis (AS) artificial intelligence imaging technology in the US, according to a Friday Australian bourse filing.

It added that it had not received an indication of the panel votes at the time of the filing, despite media speculation. Results will be posted by the association in the coming two to four weeks.

The firm's shares fell 18% in recent trading on Friday.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10